Skip to main content

Table 2 Risk factors for HBeAg positivity

From: Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study

 

N

Odds ratio univariable analysis

p-value

Odds ratio multivariable analysis

p-value

Sex

391

    

Female

170

1

0.61

  

Male

221

1.12 (0.71–1.78)

   

Age

391

0.98 (0.97–0.99)

0.04

0.98 (0.96–0.99)

0.02

Genotype

391

    

A

67

1

 

1

 

B

31

0.96 (0.38–2.45)

0.93

0.79 (0.23–2.65)

0.70

C

36

2.63 (1.14–6.07)

0.02

1.99 (0.67–5.91)

0.22

D

222

0.77 (0.42–1.42)

0.41

1.57 (0.70–3.54)

0.28

E

28

0.94 (0.36–2.49)

0.90

1.37 (0.35–5.35)

0.64

F

7

3.13 (0.64–15.30)

0.16

4.11 (0.73–23.10)

0.11

Region of origin

391

    

Switzerland

63

1

 

1

 

Europe and Mediterranean

161

0.34 (0.18–0.66)

0.01

0.24 (0.10–0.57)

0.01

Sub-Saharan Africa

39

0.64 (0.27–1.51)

0.31

0.42 (0.11–1.53)

0.19

Asia

89

1.27 (0.66–2.45)

0.48

1.03 (0.41–2.58)

0.94

Unknown and Other

39

0.81 (0.35–1.88)

0.63

0.53 (0.20–1.40)

0.20

HIV Status

228

 

0.03

 

0.11

HIV positive

15

4.51 (1.45–14.01)

 

2.53 (0.82–7.84)

 
  1. 95 % Conf. Interval in brackets; HIV Human Immunodeficiency virus